Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Global Biotechnology Contract Manufacturing Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Region, and Segment Forecasts, 2023 – 2030 Global Biotechnology Contract Manufacturing Market was valued US$ 16.5 Billion in 2022 and is expected to reach ~US$ 36.5 Billion by 2032, growing at a CAGR of 8.3% ... Read More
-
2024 Global Forecast for Single-Use Bioreactors Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
Global Large and Small Scale Bioprocessing Market Size study, by Product (Filtration Assemblies, Bioreactors/Fermenters, Cell Culture Products, Others), by Workflow (Downstream Processing, Fermentation, Upstream Processing), by Scale (Small Scale, Industrial Scale), by Application (Environmental Aids, Biopharmaceuticals, Speciality Industrial Chemicals, Others) and Regional Forecasts 2022-2032
... Biopharmaceuticals, Speciality Industrial Chemicals, Others) and Regional Forecasts 2022-2032 Global Large and Small Scale Bioprocessing Market is valued at approximately USD 57.08 billion in 2023 and is anticipated to grow with a healthy growth rate ... Read More
-
2024 Global Forecast for Spine Biologics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Single-Use Bioprocessing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Stainless Steel Suspension Cell Culture Bioreactor Market Growth 2024-2030
... is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “Stainless Steel Suspension Cell Culture Bioreactor Industry Forecast” looks at past sales and reviews ... Read More
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2024
... used primarily to treat various retinal diseases, including age-related macular degeneration (AMD) and diabetic retinopathy. These biosimilars undergo rigorous testing to demonstrate their equivalence in terms of safety, efficacy, and quality to the reference product, ... Read More
-
Global Biosimilars and Innovative Biological Drugs Market Growth (Status and Outlook) 2024-2030
... factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Biosimilars
... of 20.1% over the analysis period 2023-2030. Recombinant Non-glycosylated Proteins, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$62.4 Billion by the end of the analysis ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Global Cell Culture Micro Bioreactor Market Growth 2024-2030
... downstream market, the Cell Culture Micro Bioreactor is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More
-
2024 Global Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Single Use Bioprocessing Market Size, Share & Trends by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global
... single-use bioprocessing market is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029. The growth of this ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Biologics Contract Development and Manufacturing Organization (CDMO) Market Forecasts to 2030 - Global Analysis By Product (Biosimilars, Biologics and Other Products), Service (Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO)), Type, End User and By Geography
... By Geography According to Stratistics MRC, the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market is accounted for $14.54 billion in 2024 and is expected to reach $33.45 billion by 2030 growing at a ... Read More
-
Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2024-2030
... The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023 and expected to reach USD 627.19 billion in 2024, at a CAGR 9.74% to reach USD 1,100.51 billion by 2030. Biopharmaceuticals, also known ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2024-2030
... was estimated at USD 4.21 billion in 2023 and expected to reach USD 4.58 billion in 2024, at a CAGR 8.81% to reach USD 7.62 billion by 2030. Clinical trial equipment & ancillary solutions are ... Read More
-
Aseptic Sampling Market by Type (Automated Aseptic Sampling, Manual Aseptic Sampling), Technique (At-Line Sampling Technique, Off-Line Sampling Technique, On-Line Sampling Technique), Component, Application, End User - Global Forecast 2024-2030
... estimated at USD 968.85 million in 2023 and expected to reach USD 1,072.28 million in 2024, at a CAGR 10.96% to reach USD 2,007.50 million by 2030. Aseptic sampling is a critical process in various ... Read More
-
Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030
... Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030. Clinical trial supply & ... Read More
-
Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Global Forecast 2024-2030
... 233.44 million in 2023 and expected to reach USD 282.42 million in 2024, at a CAGR 21.30% to reach USD 902.23 million by 2030. Continuous bioprocessing represents a paradigm shift in the production of biopharmaceutical ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
Research Assistance
